Please Wait
Applying Filters...
menu
    • menu

    Information, Expiry & Status of Health Canada Patents covering Amifostine.

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Amifostine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Osler, Hoskin & Harcourt LLP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Osler, Hoskin & Harcourt LLP

    Amifostine
    arrow
    AAPS 2024
    Not Confirmed

    Osler, Hoskin & Harcourt LLP

    Country
    arrow
    AAPS 2024
    Not Confirmed

    Patent Expiration Date : 2013-07-30

    Date Granted : 1998-06-09

    Amifostine

    Brand Name : ETHYOL

    Patent Number : 2120133

    Filing Date : 1993-07-30

    Strength per Unit : 500 mg

    Dosage Form : Sterile Lyophilized Powder for Injection

    Human Or VET : Human

    Route of Administration : intravenous

    Patent Expiration Date : 2013-07-30

    Date Granted : 1998-06-09

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF